Sequence variants in host cell factor C1 are associated with Ménière's disease

Jeffrey T Vrabec1, Liqian Liu, Bingshan Li

  • 1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, U.S.A. jvrabec@bcm.edu

Abstract

Insights

Genetic factors may influence Ménière

Area of Science:

  • Genetics
  • Otolaryngology
  • Molecular Biology

Background:

  • The etiology of Ménière's disease (MD) remains unknown.
  • Familial cases and higher prevalence in Caucasians suggest a potential genetic link.
  • Autosomal dominant inheritance patterns have been observed in some families.

Purpose of the Study:

  • To investigate the genetic basis of Ménière's disease.
  • To identify specific genes and genetic variations associated with MD development.

Main Methods:

  • A case-control association study was conducted.
  • Candidate genes were analyzed in patients with MD and control individuals.
  • Single-nucleotide polymorphisms (SNPs) were examined.

Main Results:

  • Specific SNPs in the host cell factor C1 (HCFCI) gene were more prevalent in MD patients.
  • The major allele of rs2266886 showed a significant association with MD.
  • The minor allele at rs2266886 was associated with a reduced risk of developing MD (OR=0.26).

Conclusions:

  • The minor alleles of identified SNPs in HCFCI may confer protection against MD.
  • Individuals with these protective alleles appear to have a reduced risk of developing the disease.
  • Further research is needed to understand the functional impact of these HCFCI SNPs and their interaction with viral proteins like VP16.

Related Concept Videos

Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life